Literature DB >> 19954843

Proteome differences of placenta between pre-eclampsia and normal pregnancy.

B Gharesi-Fard1, J Zolghadri, E Kamali-Sarvestani.   

Abstract

Placenta is a tissue unique to pregnancy and despite its major role in pregnancy, little is known about the proteome changes within placenta during pregnancy-related diseases such as pre-eclampsia (PE). Therefore, the aim of this study is the analysis of proteome differences between pre-eclamptic and normal full-term placentas. To achieve this goal, five normal and five severe pre-eclamptic placentas were included in this study. Total placental proteins were extracted and subjected to two-dimensional polyacrylamide gel electrophoresis (2D-PAGE). After staining, the gels were scanned and the protein spots were analysed using Image Master 2D Platinum Software. Non-parametric Mann-Whitney test was used for analysis of the mean intensity differences of the spots between normal and pre-eclamptic placentas. Statistical analysis indicated that 17 spots were differently expressed in pre-eclamptic compared with normal placentas (p<0.05). Using Matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI TOF/TOF) mass analysis, 11 out of 17 spots were identified. Among them, four proteins (chloride intracellular channel 3, apolipoprotein A-I, transthyretin (TTR) and protein disulphide isomerase) were up-regulated while seven (peroxiredoxin 2, peroxiredoxin 3, Hsc 70, Cu/Zn-superoxide dismutase (SOD-1), actin gamma 1 propeptide, chain A of enoyl-coenzyme A hydratase and HSP gp96) showed decreased expression in PE in comparison with normal placentas. In conclusion, down-regulation of proteins with anti-oxidant activities (peroxiredoxin 2 and peroxiredoxin 3) and altered expression of stress-response proteins (Hsc 70, Hsp gp96 and protein disulphide isomerase) might play an important role in the pathogenesis of PE. 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19954843     DOI: 10.1016/j.placenta.2009.11.004

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  28 in total

1.  Expression profile of C19MC microRNAs in placental tissue in pregnancy-related complications.

Authors:  Ilona Hromadnikova; Katerina Kotlabova; Marketa Ondrackova; Petra Pirkova; Andrea Kestlerova; Veronika Novotna; Lucie Hympanova; Ladislav Krofta
Journal:  DNA Cell Biol       Date:  2015-03-31       Impact factor: 3.311

2.  Proteome differences in the first- and third-trimester human placentas.

Authors:  Behrouz Gharesi-Fard; Jaleh Zolghadri; Eskandar Kamali-Sarvestani
Journal:  Reprod Sci       Date:  2014-09-08       Impact factor: 3.060

3.  Rosiglitazone augments antioxidant response in the human trophoblast and prevents apoptosis†.

Authors:  Hamid-Reza Kohan-Ghadr; Brian A Kilburn; Leena Kadam; Eugenia Johnson; Bradley L Kolb; Javier Rodriguez-Kovacs; Michael Hertz; D Randall Armant; Sascha Drewlo
Journal:  Biol Reprod       Date:  2019-02-01       Impact factor: 4.285

4.  Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaa.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Amy Whitten; Adi L Tarca; Gaurav Bhatti; Sorin Draghici; Piya Chaemsaithong; Jezid Miranda; Sonia S Hassan
Journal:  J Perinat Med       Date:  2013-09-01       Impact factor: 1.901

5.  A review of omics approaches to study preeclampsia.

Authors:  Paula A Benny; Fadhl M Alakwaa; Ryan J Schlueter; Cameron B Lassiter; Lana X Garmire
Journal:  Placenta       Date:  2020-01-22       Impact factor: 3.481

6.  A placental sub-proteome: the apical plasma membrane of the syncytiotrophoblast.

Authors:  D D Vandré; W E Ackerman; A Tewari; D A Kniss; J M Robinson
Journal:  Placenta       Date:  2012-01-04       Impact factor: 3.481

7.  Human placental transthyretin in fetal growth restriction in combination with preeclampsia and the HELLP syndrome.

Authors:  Arrigo Fruscalzo; R Schmitz; W Klockenbusch; G Köhler; A P Londero; M Siwetz; B Huppertz
Journal:  Histochem Cell Biol       Date:  2012-07-31       Impact factor: 4.304

8.  The placenta in preeclampsia.

Authors:  James M Roberts; C Escudero
Journal:  Pregnancy Hypertens       Date:  2012-04-01       Impact factor: 2.899

9.  Proteomic evaluation of sheep serum proteins.

Authors:  Elisabetta Chiaradia; Luca Avellini; Micaela Tartaglia; Alberto Gaiti; Ingo Just; Fausto Scoppetta; Zoltan Czentnar; Andreas Pich
Journal:  BMC Vet Res       Date:  2012-05-25       Impact factor: 2.741

Review 10.  Utility of proteomics in obstetric disorders: a review.

Authors:  Jónathan Hernández-Núñez; Magel Valdés-Yong
Journal:  Int J Womens Health       Date:  2015-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.